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BRCT domains, present in a large number of proteins that are
involved in cell cycle regulation and/or DNA replication or repair,
are primarily thought to be involved in protein-protein interac-
tions. The large (p140) subunit of replication factor C contains a
sequence of100 amino acids in the N-terminal region that binds
DNA and is distantly related to known BRCT domains. Here we
show that residues 375–480, which include 28 amino acids N-ter-
minal to the BRCT domain, are required for 5-phosphorylated
double-stranded DNA binding. NMR chemical shift analysis indi-
cated that the N-terminal extension includes an -helix and con-
firmed the presence of a conserved BRCT domain. Sequence align-
ment of the BRCT region in the p140 subunit of replication factor C
from various eukaryotes has identified very few absolutely con-
served amino acid residues within the core BRCT domain, whereas
nonewere found in sequences immediatelyN-terminal to theBRCT
domain. However, mapping of the limited number of conserved,
surface-exposed residues thatwere foundonto ahomologymodel of
the BRCT domain, revealed a clustering on one side of the molecu-
lar surface. The cluster, as well as a number of amino acids in the
N-terminal -helix, were mutagenized to determine the impor-
tance for DNA binding. To ensure minimal structural changes
because of the introduced mutations, proteins were checked using
one-dimensional 1H NMR and CD spectroscopy. Mutation of
weakly conserved residues on one face of the N-terminal -helix
and of residues within the cluster disrupted DNA binding, suggest-
ing a likely binding interface on the protein.
The BRCA1 C-terminal homology (BRCT) domain is an abundant
structural unit (1, 2) found inmore than 900 proteins from all biological
kingdoms as listed in the Uniprot data base.3 Nearly all of these proteins
are involved in the cell cycle checkpoint response to damaged DNA
and/or more directly in DNA replication or repair. The BRCT super-
family has been further classified into three subsets. The first consists of
a core of highly conserved domains found in proteins such as BRCA1
itself, the Saccharomyces cerevisiae Rad9 protein and the p53-binding
protein 53BP1. A second distinct and more distantly related set can be
found in DNA binding enzymes such as the bacterial NAD-dependent
ligases and poly(ADP-ribose) polymerase. Finally, the retinoblastoma
tumor suppressor and related proteinsmay contain a very distantmem-
ber of the BRCT family (1).
BRCTdomains are responsible for a number of important homo- and
heterotypic protein-protein interactions. For instance, XRCC1, a pro-
tein involved in repair of single-strandedDNAbreaks, bindsDNA ligase
III via its C-terminal BRCT domain (3), whereas its N-terminal BRCT
domain specifically binds poly(ADP-ribose) polymerase (4). Other
BRCT domains, such as those in the S. cerevisiae protein Rad9, function
in homotypic (self) protein binding (5). Recently, it has been shown that
many BRCT domains posses a phosphoserine-specific, protein binding
function (6–8). Finally, a growing number of BRCT domains appear to
bindDNA.The best characterized is the BRCT from the large subunit of
replication factor C (RFC)4 (9). The DNA binding characteristics of
other BRCT domains, however, remain less well characterized (10, 11).
The BRCT domain consists of roughly 90 amino acids (1, 2). Struc-
tural information is available for an increasing number of BRCT
domains, including those from XRCC1 (12), BRCA1 (13), 53BP1 (14,
15), DNA ligase III (16), and the bacterial NAD-dependentDNA ligase
(17). Despite the sequence divergence, all of these structures display a
conserved fold consisting of a four-stranded, parallel -sheet sur-
rounded by three -helices. However, the way in which these domains
interact with known ligands varies widely. For instance, the interaction
between the C-terminal BRCT domain of XRCC1 and the BRCT
domain ofDNA ligase III occurs through residues in the1 helix of each
domain (18). BRCA1 also contains two BRCT domains; however, they
form an obligate paired structural unit that specifically binds to a phos-
phoserine containing sequence in the protein BACH1 (19–21). Hence,
despite conservation of the three-dimensional structure of each
domain, the mechanism by which BRCT domains execute their func-
tion differs significantly within the BRCT superfamily.
RFC is a five-protein complex involved in both the replication and
repair of chromosomal DNA (22–24). The primary function of RFC
appears to be to open the “sliding clamp” protein PCNA and “load” it
onto DNA where it serves as a binding platform for a multitude of
enzymes and regulatory proteins involved in the replication and repair
of DNA. RFC consists of four subunits of between 35 and 40 kDa that
share homology with a central region of the fifth subunit, which has a
molecular mass of 140 kDa in mammals (referred to as p140). The
N-terminal half of the p140 subunit contains sequences unique to RFC,
including a region with DNA binding activity (9, 25–27) that is not
required for clamp loading (28, 29). This region contains amino acid
sequences, which form part of the second, distinct class of BRCT
domains (1, 2). Here we demonstrate that this region of p140 does
indeed contain a BRCT domain but that additional sequences outside
the domain are required for 5-phosphate-specific, double-stranded
DNA binding. Using mutagenesis we define a model of the protein-
DNA complex.
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MATERIALS ANDMETHODS
Cloning—The plasmid containing a cDNA clone coding for residues
369–480 of human RFC p140 was a kind gift of Prof. Ullrich Hu¨bscher
(Universita¨t Zu¨rich, Switzerland). The three different constructs were
generated using standard PCR-based methods and were cloned into
pET20b (Novagen) with a C-terminal His6 tag.
Site-directed Mutagenesis—The procedure for generating point
mutationswas adopted from theQuikChangemethod (Stratagene)with
some modifications. A DpnI-treated, nicked plasmid was transformed
into highly competent Escherichia coli DH5 cells (108 colonies/g).
Plasmid carrying the desired mutation was identified by the unique
silent restriction site introduced via the mutagenesis primers and was
subsequently verified by DNA sequencing. The (R388A) mutation, was
generated using splice overlap extension (30).
Protein Expression and Purification—Proteins were expressed for 3 h
at 37 °C in BL21(DE3)/pLysS cells (Novagen). Lysed cells were centri-
fuged at 20,000 g for 30 min at 4 °C and the supernatant applied to a
6-ml metal chelate column (Novagen) charged with Ni2. The column
was developed per the manufacturer’s recommendations. Fractions
containing the His-tagged protein, as judged by SDS-PAGE, were
pooled, and EDTA was added to the protein solution to a final concen-
tration of 5 mM to chelate Ni2 leached from the column. The protein
solution was concentrated through an Amicon ultrafiltration device
(YM10membrane) to 5-ml volume. The protein was further purified to
apparent homogeneity using a 140-ml (1.6 75 cm) column of Super-
ose 12 (AmershamBiosciences) equilibratedwith 20mMTris, pH7.5, 50
mM NaCl and 1 mM dithiothreitol. All proteins were stably stored at
4 °C.
Preparation of Oligonucleotides—The sequences of all oligonucleo-
tides used in this study are presented in Table 1. The oligonucleotides
were synthesized using standard solid state methods including the
5-PO4 (with the exception noted in Table 1). When labeling was
required, 2 pmol of 5-phosphorylated oligonucleotide were used in an
exchange reaction employing phage T4 polynucleotide kinase and 20
pmol of [-32P]ATP as substrate. To ensure a very high percentage of
double-stranded DNA, the hairpin oligonucleotides were subsequently
denatured at 100 °C for 10 min and then slowly cooled to room
temperature.
Circular Dichroism (CD) Spectroscopy—RFC p140 proteins were
exchanged into a buffer consisting of 10 mM NaCl, 1 mM KH2PO4, 10
mMNa2PO4, pH 7.5, and 2.7mMKCl. Each protein was diluted to 10M
in the same buffer. CD spectra were recorded on a Jobin Yvon CD6
instrument at 1-nm intervals over 190–240 nmwavelength at 21 °C in a
0.5-mm path length cuvette. Each of the purified mutants was
exchanged into the same K/Na phosphate buffer using PD10 col-
umns (Amersham Biosciences). CD spectra of the mutants (K397E,
T415A, R423A, K458E, and wild type) were measured at 21 °C with
scanning at 1-nm increments between 195–260 nm in a 0.1-mm path
length cuvette. For each protein, five spectra were recorded to obtain an
average spectrum from which the background spectrum of the buffer
was subtracted.
Stoichiometric Titration—10 M oligo 1 (in 25 mM Tris-HCl, pH 7.5,
50 mM NaCl and 1 mM dithiothreitol) was mixed with the indicated
amount of RFC p140-(375–480) (in the identical buffer) in a final vol-
ume of 250 l. The DNA-protein complex was separated from the free
DNA on a Superdex 10/300 GL column (Tricorn) at a flow rate of 1.5
ml/min. The absorbance peaks at 260 nm, corresponding to protein-
DNA complex and free DNA, were fitted with a Lorenzian curve and
subsequently the area underneath the curves was integratedwith a trap-
ezoidal function using SIGMAPLOT7.0. The fraction of protein-bound
DNA was then calculated by dividing the area of the peak representing
the complex by the sum of the area of the complex and the free DNA
peaks.
Detection of Protein-DNA Complexes—DNA binding was detected
using a gel retardation assay. The indicated amount of the various RFC
p140 proteins were diluted in a buffer of 10 mM HEPES, pH 7.8, 2 mM
MgCl2, 0.1 mM EDTA, 100 g/ml bovine serum albumin, 15% glycerol,
0.8 g/ml poly(dI-dC) and 2 mM dithiothreitol. The indicated amount
and appropriate volume of 5-32P-labeled oligonucleotide was added to
the mixture to a final volume of 12 l, which was subsequently incu-
bated on ice for 15 min and then applied to a non-denaturing 8% Tris-
glycine acrylamide gel and electrophoresed at 150V for 30min at 4 °C in
25 mM Tris-HCl pH 8.5, 200 mM glycine, 1 mM EDTA (TGE) buffer.
Radioactivity was detected photographically (X-OMAT, Kodak) or
using a PhosphorImager (Bio-Rad) after the gel was dried. The fraction
of DNA in the DNA-protein complex was calculated as the percentage
of total shift (%)  [complex  background]/[total activity per lane 
background]  100, where total activity  complex  free DNA. Gel
retardation was also used to determine the ligand (DNA) requirements
for binding but in the form of a competition assay. In these experiments
both labeled and unlabeled DNA were premixed and then added to the
protein solution. The amount of the competing oligonucleotide used in
excess over the labeled oligonucleotide in each assay is indicated in the
figure legend. To determine the KD of the protein-DNA complex, a
constant amount of radiolabeled oligo 1 was titrated with an increasing
amount of protein. The fraction of protein bound-DNAat each titration
point was determined as described above. KD was determined by itera-
tive fitting of Equation 1 (31),

Dtot Ptot KD Dtot Ptot KD2 4	Dtot	 Ptot
2	Dtot
(Eq.1)
using SIGMAPLOT 7.0 assuming a 1:1 protein-DNA complex (see
results), where v is the fraction of the bound DNA,Dtot is the total DNA
concentration, and Ptot is the total protein concentration.
NMR Measurements—Protein samples were prepared for NMR
spectroscopy and analyzed as reported earlier (32). The consensus
chemical shift index (CSI) score was generated with the program CSI
version 1.0 (33) from 13C, 13C, and 1H chemical shifts values as
inputs. Protein concentration varied from 0.05 to 0.1mM as determined
by UV absorbance at 277 nm. One-dimensional 1H NMR spectra of
each protein were recorded on a 500-MHz Bruker AVANCE instru-
ment at 298 K (25 °C) and processed with TOPSPIN 1.3 (Bruker).
RESULTS
Identification of Protein Domains Required for DNA Binding Activity—
The DNA binding domain of human RFC p140 was initially defined as
consisting of residues 369–480 (25). Because this region includes
sequences outside the conserved BRCT domain wewere interested to find
outwhether just theBRCTdomain-(403–480) itselfwas sufficient forDNA
binding. Based on the published sequence alignments (1, 2) wemade three
N-terminal deletion constructs whose C termini all coincide with the
expected C terminus of the BRCT domain. All three-deletion constructs
were C-terminally tagged with six histidines, expressed in E. coli and sub-
sequently purified to apparent homogeneity using metal chelate and gel-
filtration chromatography. The three proteins behaved somewhat differ-
ently on the gel-filtration column (Fig. 1A). Although p140-(375–480)
eluted with a retention time expected of a 12-kDa monomer, p140-(403–
DNA Binding by the RFC p140 BRCT Region
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480) eluted as a broad peak corresponding to an estimatedmolecularmass
of 18 kDa (Fig. 1A) as well as in an aggregate that elutes at the position
expected of a 100-kDa protein. This data suggests that the core BRCT
domain is inequilibriumbetweenmono-, di-, andpossibly trimeric states in
solution. p140-(392–480) eluted slightly faster than expected, correlating
with an approximate molecular mass of 15 kDa (Fig. 1A), which is some-
what larger than the expected value (10 kDa). The secondary structure of
the three constructs was analyzed using CD spectroscopy (Fig. 1B). All
three proteins gave rise to similar CD spectra suggesting a shared fold that
remained intact even in the smallest protein. Predictionof secondary struc-
ture content fromtheCDspectrausing theprogramK2d (34) shows that all
of the peptide constructs contained a mixture of  and  structures, as
would be expected of a BRCT domain.
Each of the three proteins was tested for DNA binding using a gel
retardation assay inwhich purified proteinswere titrated into a constant
amount of a 5-32P-labeled oligo 1 (Fig. 1C; all DNA binding assays were
performed in the presence of excess, unlabeled poly(dI-dC).). Oligo 1
(Table 1), which is used in all subsequent experiments, consists of a
10-bp double-stranded region connected by a 4 base hairpin turn and
contains a 4 base recessed 5-end. Only the protein containing 28 resi-
dues N-terminal to the predicted boundary of the BRCT domain (p140-
(375–480)) demonstrated DNA binding activity. Given the CD data
that indicates that the isolated BRCT domain remains folded, the DNA
binding data suggest that sequences N-terminal to the conserved BRCT
domain are directly required for DNA binding. We refer to this
TABLE 1
Sequences of oligonucleotides used in this study
For hairpin oligonucleotides, the hairpin sequence is highlighted with bold letters.
The unpaired bases of oligo 2 are underlined. A “p” indicates 5-PO4, whereas “b”
indicates a 5-biotinylated.
FIGURE 1. Characterization of RFC p140 BRCT-containing proteins. The predicted RFC p140 BRCT domain includes residues 403–480. Three different RFC proteins, amino acids
375–480, 392–480, and 403–480were purified from E. coli cells and characterized as follows. A, gel-filtration chromatography using Superose 12 resin. The elution profile of each of
the three different RFC proteins is shown with peaks containing the relevant protein indicated by an asterisk. The calibration set contained proteins of 670 (a), 158 (b), 44 (c), 17 (d),
6.5 (e) and 1.3 kDa (f), which were used to estimate the molecular weight of the RFC proteins (see text). Vo represents the void volume of the column. B, the far UV-CD spectra of all
threeproteins have characteristicminima at 208 and220nm, reflecting-helical and-strand content, respectively. Thepercentageof each secondary structurewaspredictedusing
theprogramK2d (34).C, a gel retardation assaywasused todetect binding to the5-32P-labeledoligodeoxynucleotide (oligo1, Table 1) by eachof theproteins. An increasingamount
(40, 200, or 400 fmol) of the indicated constructs of hRFC p140 was titrated into 40 fmol of DNA. The asterisk denotes a control in which no protein was added to the DNA. The black
arrow indicates the position of the DNA-protein complex, and the gray arrow indicates that of the unbound DNA.
DNA Binding by the RFC p140 BRCT Region
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extended, minimal DNA-binding protein as the BRCT region to indi-
cate the requirement for amino acid sequences notwithin the conserved
BRCT domain.
Specificity of DNA Binding—We wished to further characterize the
nature of the protein-DNA complex. Because the stoichiometry of the
complex was not clear from previous reports, an increasing amount of
p140-(375–480) was titrated into a constant amount of 10-bp oligo 1
(Table 1) until saturation of binding was clearly achieved. The protein-
DNA complex was separated from unbound DNA using gel-filtration,
and the amount of free DNA and DNA-protein complex was quantified
to determine the fraction ofDNA-bound protein. The fraction of bound
DNA increased nearly linearly with increasing protein until a protein-
DNA ratio of 1.25:1 at which binding begins to saturate. (Fig. 2A). Given
the slope and saturation point, the binding curve strongly suggests a 1:1
protein-DNA ratio in the complex. To accurately measure theKD of the
complex, the titration was repeated using the gel retardation assay. The
steps in the titration were more closely spaced about the estimated KD
for the complex. Fitting of the binding isotherm, assuming a 1:1 stoichi-
ometry as suggested above, yielded an apparent KD of 10 nM (not
shown). To determine the length of duplex DNA required for optimal
binding a series of oligonucleotides was synthesized that systematically
reduced this region but left the overall base content intact (Table 1). The
series of shorter oligonucleotides was titrated into 32P-labeled 10-bp
oligo 1, and binding was determined using gel retardation in the form of
a competition assay. Fig. 2B demonstrates that DNA with a duplex
region as short as 7 base pairs can effectively compete with the labeled
oligo 1, but for maximal binding 9–10 base pairs are required. Duplex
regions greater than 10 base pairs did not result increased binding affin-
ity (not shown). In addition, fully base-paired DNA forms the best
ligand because a mismatched Watson-Crick base pair 6 nucleotides
away from the 5-phosphate (oligo 2) reduced the affinity of the protein-
DNA interaction (Fig. 2B).
The gel shift competition assay was subsequently used to assess the
determinants for binding to the 5-end of dsDNA (Fig. 2C). Using a
protein concentration close to KD, competition binding between two
different oligonucleotide ligands was performed by mixing the 5-32P-
labeled oligo 1 (10 base pairs) with oligonucleotides with various
5-chemistries (Table 1) prior to the addition of p140-(375–480). As
expected from previous studies (9, 25), binding to the 5-phosphoryl-
ated hairpin oligonucleotide could not be competed with dsDNA con-
taining either a 5-OH or a 5-biotin, nor a 5-OH single-stranded oli-
godeoxynucleotide (Fig. 2C). Competition with a 5-phosphorylated
single-stranded DNA was just detectable, indicating a weak affinity of
the protein for this ligand. Finally, competition was slightly more effec-
tive with dsDNA with a recessed 5-phosphate end than with blunt
ended DNA (Fig. 2C) correlating with the earlier report that the Dro-
sophilaRFCp140 binds 5-end recessed dsDNAbetter than blunt ended
DNA (9). DNA binding was also insensitive to salt up to 500 mM NaCl
and not dependent on Mg2 (data not shown).
Structural Characterization of the RFC p140 BRCT Region—Because
the minimal DNA binding domain includes sequences N-terminal to
the conserved BRCT domain, we wished to ascertain whether or not it
contained elements of regular secondary structure. As a first approach
we used the PSIPRED secondary structure prediction service (35).
Sequences within the first 28 amino acids of the BRCT region were
predicted to form an -helix with a high degree of confidence (Fig. 3A).
The secondary structure expected of a BRCTdomainwas also predicted
between amino acids 403 and 480. As a control we performed a similar
analysis on other BRCT domain sequences with known structures and
obtained a close correlation between the predicted and experimentally
determined elements of secondary structure. For comparison, the sec-
ondary structure as determined by NMR of the BRCT domain from the
bacterial NAD-dependent DNA ligase, which is 53% homologous to
RFC p140-(403–480), is shown in Fig. 3A. The PSIPRED-predicted sec-
ondary structure (not shown) is 99% identical. We also performed a
secondary structure prediction on a number of other BRCT-containing
proteins including the trans-lesion polymerase Rev1. Rev1 contains a
consensus BRCT domain near its N terminus (Fig. 3A). Interestingly,
PSIPRED predicts an N-terminal -helix in a position analogous to that
FIGURE 2. Characterization of the requirements of RFC p140-(375–480) for DNA
binding. A, stoichiometric titration of the protein-DNA complex. A constant amount of
oligo 1 (10 M) was titrated with an increasing amount of RFC p140-(375–480), and the
resulting DNA-protein complex was separated from the unbound DNA through an ana-
lytical gel-filtration column. B, competition gel retardation assay to characterize the
extent of dsDNA required for binding. 40 fmol of 32P-labeledoligo1wasmixedwith a 10-
or 60-fold excess of the indicatedunlabeledDNA (see Table 1) and subsequently allowed
to bind to 200 fmol of protein. The black arrow indicates the position of the DNA-protein
complex, and the gray arrow indicates that of the unbound DNA. C, the competition gel
retardation assay was used to delineate the chemical features of DNA required for bind-
ing by RFC p140-(375–480). 40 fmol of 5-32P-labeled oligo 1 was mixed with a 50-fold
excess of the competing DNA, and subsequently 200 fmol of protein was added. The
competing DNA was a unlabeled oligo 1 (5P), 5-PO4 blunt end (5Pb) hairpin-oligonu-
cleotide, 5-PO4 single-stranded (5Ps) oligonucleotide, 5-OHversion of oligo 1 (5OH), a
single stranded (ss) and a 5-biotinylated, 20-base-pair, blunt ended oligonucleotide
(5B).
DNA Binding by the RFC p140 BRCT Region
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of Rfc1. Preliminary analysis indicates that the Rev1 BRCT region does
indeed bind dsDNA.5
NMR is a powerful tool to characterize the solution structure of pro-
teins (36). A significant advantage of NMR is that it can quickly provide
information on the folded state of a protein by simple visual inspection
of spectra. Further, it is possible to accurately determine the secondary
structure of a protein based solely on backbone resonance assignments.
Accordingly, we have used 13C,15N-labeled protein in conjunction with
standard triple resonance NMR experiments, to determine the essen-
tially complete sequential assignment of the p140-(375–480)-DNA
complex (32) and have obtained a preliminary backbone assignment of
the free protein. The NMR data (Fig. 3B) suggest that the solution
behavior of p140-(375–480) is very different in the absence or presence
of DNA. The two-dimensional [15N,1H] HSQC experiment, which
detects the 1 bond correlation within an amide moiety, can be used to
determine the folded state of a protein, to a first approximation, by
analyzing the dispersion and line width of the peaks in the spectrum.
Because one peak should be observed for every non-prolyl residue, the
chemical shift and line width are good indicators if that residue is well
structured and/or undergoing conformational or chemical exchange.
The spectra in Fig. 3B imply that large portions of p140-(375–480) are
conformationally flexible in the absence of DNA as indicated by the
poor dispersion of resonances (see the overlapped peaks in the region
from 7.8 to 8.6 ppm) and by the presence of very broad peaks indicative
of exchange that is intermediate on the NMR time scale (e.g. kex 
	
(Hz), indicated by arrows in Fig. 3B). It is for this reason that the
sequential assignment of the isolated protein is incomplete. In contrast,
the spectrum of the DNA-bound protein in Fig. 3B shows good peak
dispersion andmore uniform line width, despite the fact that it is part of
a complex that is nearly twice as large. These data suggest that the
DNA-bound protein experiences reduced dynamic behavior and that
likely, a number of amide 1Hs are protected from exchange with the
solvent.
Once the sequential chemical shift assignment of a protein is known,
theCSI is a usefulmeans of correlating the so-called secondary chemical
shift (the difference between the observed chemical shift and that
expected for the same residue in random coil) with the secondary struc-
ture of a protein (33). We used CSI analysis of the NMR data to deter-5 M. Kobayashi, F. Figaroa, and G. Siegal, manuscript in preparation.
FIGURE 3. Structural analysis of RFC p140-(375–480). A, sequence alignment of the BRCT domains of bacterial NAD-dependent ligase (DNLJ_THET8), human
Rev1(REV1_HUMAN), and human RFC p140 (RFC1_HUMAN)was performed using ClustalW. In the alignment, residueswith sequence identity
60%or similar properties are shaded
black or gray, respectively. AMAS analysis of the sequence alignment of RFC p140 from 31 eukaryotic species identified only a few highly conserved residues, which are presented in
capital letters below the alignment. The secondary structure elements, arrows for -strands and rectangles for -helices, are aligned with the corresponding amino acid sequences
based on the NMR structure of the BRCT domain from the NAD-dependent ligase (PDB: 1L7B) or the PSIPRED (26) prediction of Rev1-(15–120) and RFCp140-(375–480). The
consensus secondary structure of hRFC p140-(375–480) determined by the CSI methodwas generated from the NMR assignment using the C, C, and H chemical shifts as input.
B, two-dimensional [15N,1H]HSQCNMRspectra of RFCp140-(375–480)without (left) andwithDNA (oligo1, right). NMR spectraweremeasured at 298Kat 600MHz. Examples of some
of the resonances with unusually broad lines, indicating intermediate exchange behavior, are indicated by arrows.
DNA Binding by the RFC p140 BRCT Region
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mine the secondary structure of the DNA-bound RFC p140-(375–480)
(Fig. 3A). The secondary structure of residues 403–480 is consistent
with that of other BRCT domains whose three-dimensional structure
has been determined and closely matches that predicted by PSIPRED.
Importantly, the -helix between residues 379 and 386 that is predicted
by PSIPRED is experimentally confirmed by the CSI analysis of the
backbone chemical shifts. Our preliminary backbone resonance assign-
ment of RFC p140-(375–480) in the absence of DNA indicates that the
secondary structural elements are retained but they are shorter. This
analysis is complicated by the remaining gaps in the sequential assign-
ment of the isolated p140-(375–480). However, the reduced secondary
structure content in the free protein suggested by the NMR analysis is
supported by the secondary structure prediction based on the CD spec-
trum of the free p140-(375–480) (Fig. 1C), fromwhich we estimate that
26 and 15% of all amino acids are in -helices or -strands, respectively.
The CD-derived values of the free protein compare with the CSI-pre-
dicted values of 31 and of 21% for -helices and -strands, respectively,
in the DNA complex (Fig. 3).
Sequence Conservation Analysis—To find potential residues involved
in the recognition of DNA, a sequence alignment of the BRCT region in
the p140 subunit of 31 eukaryotic RFC complexes was analyzed using
the program AMAS (37), allowing the identification of a few highly
conserved residues within the BRCT domain (Figs. 3A and 4). In con-
trast, the N-terminal sequence of the BRCT region lacked any absolute
conservation among all 31 species despite its indispensable nature in
DNA binding. A homology model of the RFC BRCT domain (residues
403–480, Fig. 4) was generated by the program 3D-JIGSAW (38) using
the available structure of the BRCT domain from the bacterial NAD-
dependent DNA ligase (Fig. 3A). The resulting model consists of four
parallel -strands (1–4) forming the core, which are surrounded by
three -helices (1–3) (Fig. 4A). As with PSIPRED, the secondary
structure predicted by 3D-JIGSAWcloselymatched that determined by
the CSI analysis. The N-terminal sequence between residues 375 and
402 is not included in the model because of the absence of sequence
homology; hence, the N-terminal helix (379–386) and the loop (387–
402) are schematically presented as a rectangle (1) and a dotted line,
respectively (Fig. 4A, right). Most of the conserved hydrophobic resi-
dues are involved in stabilizing the core created by residues within the
parallel -strands and the -helices packed against it (12). The struc-
tural importance of these conserved hydrophobic residues in the BRCT
domain has been demonstrated by the reduced stability of the folded
protein whenmutated (18).Mapping of the solvent-exposed, conserved
residues onto the model structure reveals an interesting pattern where
the majority cluster on one molecular surface (Fig. 4B). Furthermore, a
number of these residues (Thr-415, Arg-423, Lys-458) provide the req-
uisite hydrogen bonding potential to interact with charged backbone
phosphate groups on DNA as would be expected for a non-sequence-
specific complex (40). The model therefore provides an interesting
starting point from which to base experimental analysis of the protein-
DNA interface.
The most straightforward approach to determining the involvement
of a given amino acid residue in DNA binding is mutagenesis. However,
it is important to independently determine that mutagenesis has not
severely disrupted the tertiary structure of the protein, merely the
desired local properties. Accordingly, based on sequence alignment and
the structural model, amino acid residues identified as conserved or
with an identity of at least 50% were selected for mutagenesis. Con-
served hydrophobic residues contributing purely to the stability of fold-
ing were excluded from mutagenesis. The surface-exposed GG repeat
(amino acids 434 and 435) (Fig. 4B), highly conserved throughout the
BRCT family, forms a tight turn between 1 and 2, which can be
disrupted by substitution with bulky residues (41). Therefore this
sequence was also excluded from mutagenesis. The assumption was
made that most residues involved in DNA binding would do so via salt
bridge or hydrogen bond interactions, andwe therefore selected basic or
polar residues for mutagenesis. Based on these considerations four res-
idues (Thr-415, Arg-423, Lys-458, and Lys-461) within the BRCT
domain itself were selected formutagenesis. To probe the DNAbinding
FIGURE 4. Three-dimensional model of the
sequence conservation in the BRCT domain of
RFC p140. A, ribbon presentation of the model
BRCT domain. The model was based on the NMR
structure of the BRCT domain from the bacterial
NAD-dependent DNA ligase (PDB code: 1L7B),
which has 53% sequence identity to RFC p140 and
was generated using the program 3D-JIGSAW
(38). The predicted N-terminal -helix is schemat-
ically shown as a rectangle, and the connecting
loop (387–402) is presented as a dotted line, as
there is no available homologous structure. Point
mutations created in this study are representedby
blue balls at the appropriate Cposition. B, surface
presentation of the homology modeled RFC p140
BRCTdomain. Theblue-shaded areas represent the
accessible surface occupied by the conserved
amino acids (see Fig. 3) defined from the amino
acid sequence alignment using AMAS. The posi-
tion of other residue mentioned in the text is also
indicated.
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interface of the N-terminal 1-helix, which is clearly important for
DNA binding, we also selected three residues (Tyr-382, Ser-384, Tyr-
385) as well as two residue within the connecting loop (Arg-388, Lys-
397). These residues were preferably substituted with the negatively
charged glutamic acid, if the substitution was not expected to disturb
the secondary structure as predicted by PSIPRED, otherwise with an
alanine. As a result, four residues, Tyr-385, Lys-397, Lys-458, and Lys-
461, were substituted with glutamic acid, and five residues, Tyr-382,
Ser-384, Arg-388, Thr-415, and Arg-423 were substituted with alanine
(indicated as blue balls on the structure model in Fig. 4A).
Physical Characterization of Mutated Proteins—The mutated pro-
teins each contained a 6-histidine tag at the C terminus and were puri-
fied using the identical protocol as for the wild type protein. Each
mutant protein eluted at the same position as the wild type (wt) protein
during gel filtration (not shown) suggesting that the mutations did not
result in aggregation or complete unfolding of the protein. The exist-
ence of natively folded protein in the purified fraction was further con-
firmed by one-dimensional 1HNMR spectroscopy comparing the spec-
tral region containing resonances from the backbone amide 1Hs (7–10
ppm) and aliphatic 1Hs (0–4 ppm). Fig. 5A presents the downfield
portion of the spectrum of each mutant protein in order of decreasing
similarity to the wt protein. All spectra are indicative of folded proteins,
exhibiting a similar peak dispersion and pattern to the wt protein.
Mutants T415A and R423A exhibit increased line width in comparison
FIGURE 5. Spectroscopic characterization of the
folding of mutant RFC p140-(375–480) pro-
teins. A, one-dimensional 1H NMR spectra were
recorded of each purified mutant protein (indi-
cated). Resonances that eitherdisappearor aredif-
ferent from the wt spectrum are indicated with
asterisks. The spectra are ordered in decreasing
similarity to thewtprotein (descending top tobot-
tom left and then right). The similarity of the spec-
trum of eachmutant to that of thewt protein indi-
cates a nearly native fold. B, CD spectra of the
mutants T415A, R423A, K458E, and K397E com-
pared with wild type (WT) RFC p140-(375–480).
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to the wt, indicating possible weak aggregation in solution or dynamic
behavior that is different from that of wt. There were no significant
differences in the resonances arising from aliphatic 1Hs (not shown).
The mutants (Thr-415, Arg-423, K397E, and K458E) that displayed
spectra with some deviations from the wt protein were further checked
using CD spectroscopy to determine the secondary structure content
(Fig. 5B). Because of the poor signal to noise ratio of the CD spectra, a
quantitative determination of secondary structure was not possible.
However, qualitative inspection does not indicate significant differences
betweenwt andmutant proteins. Taken together, the chromatographic,
NMR, and CD data all suggest that the mutants are natively folded with
only minor structural changes.
Effect of Mutations on DNA Binding—The effect of eachmutation on
dsDNA binding was assessed using the gel shift assay. To maximize the
sensitivity we titrated a constant amount of 5-32P-labeled, dsDNAwith
amounts of each mutant protein below and above the previously deter-
mined KD of the wt protein (Fig. 6A). Of all the mutants generated, only
S384A exhibited DNA binding equivalent to wt. Themutations, Y385E,
R388A, K458E, and K461E, essentially abrogated DNA binding activity.
Significant reductions inDNAbindingwere also observed for themuta-
tionsY382A,T415A, andR423A.Asmight be expected, the substitution
of residues with the negatively charged glutamic acid side chain gener-
ally affected DNA binding more drastically than substitution by alanine
(Fig. 6B). This observation likely reflects the greater change in surface
electrostatic potential caused by incorporation of a charged residue
than a neutral residue. The mutagenesis results suggest that one face of
the BRCT domain as well as the N-terminal helix and connecting loop
directly contact the DNA. To confirm these findings we made two fur-
ther mutants that were expected to have no impact on DNA binding.
Residue Lys-445 is in the “lower” face of the BRCT domain (Fig. 4B),
whereas Arg-480 is on the “back” face with respect to the conserved
cluster. Because both residues are highly surface-exposed we mutated
them to alanine and tested for DNA binding. As demonstrated in Fig.
6C, both mutants bound DNA with affinity similar to the wt protein.
DISCUSSION
Protein Requirements for DNA Binding—Our data clearly show that
despite the sequence divergence, amino acids 403–480 of the p140 sub-
unit of human RFC form a consensus BRCT fold. Further, the folded
BRCT domain by itself is insufficient for DNA binding. Additional
sequences N-terminal to the BRCT are required for DNA binding.
Although these additional sequences form in part, an -helix, it is not
clear whether this helix is an integral part of the folded BRCTdomain or
whether it is isolated from the core domain. It is also clear from the data
that the BRCT region is only moderately well structured in the absence
of its DNA ligand, but that it becomes more rigid, with a better defined
structure, upon DNA binding. Because the protein studied here is
removed from its normal context of the complete five-subunit RFC
complex it is not possible to say whether the behavior observed in vitro
is a reflection of the in vivo situation. Both biochemical and structural
studies, however, suggests that the entire N-terminal half of RFC
p140 is only loosely connected to the remainder of the clamp loading
complex (28, 29, 42). If so, the in vitro observations could well be rele-
vant to the in vivo function and may represent some type of regulation.
This type of behavior, structural rigidification upon ligand binding, is
rather common (43).
Specificity of DNA Binding by p140-(375–480)—Because there
appears to be no restriction on the sequences that form the duplex
region of bound DNA, it is likely that the majority of protein contacts
are made to the backbone and 5-phosphate of the DNA as observed
recently in the structure of a non-sequence-specific protein-DNA com-
plex (40). Further, the protein appears to directly contact both strands of
the duplex because 5-phosphorylated single-stranded DNA bound
only very weakly, but more subtly, an unpaired base within the duplex
had a significant negative effect on binding. Whether or not the BRCT
region actually contacts all 10 base pairs of DNA awaits the elucidation
of the structure of the complex. Alternatively, it is possible that stability
of the duplex became limiting in our gel shift experiments as the number
of base pairs was reduced. This does not seem likely however because
the entire assay was performed at 4 °C, a temperature at which even the
short 6 bases duplex should be stable in the context of a hairpin
oligonucleotide.
Model for the Protein-DNA Interaction—The face of the homology
model that contains surface-exposed, conserved residues, also bears a
large patch of positive electrostatic potential formed primarily from the
side chains of Arg-423, Lys-458, and the backbone amide of Gly-416.
Mutagenesis of the conserved, potential hydrogen bonding residues
reduces or abrogates DNA binding. Despite the lack of amino acid con-
servation in the N-terminal sequence of the BRCT region, mutagenesis
of one face of helix 1 and charged residues in the loop that connect
this helix to the BRCT domain also disrupts DNA binding. The combi-
nation of sequence conservation and mutagenesis data suggests a pos-
sible mode of DNA binding by the BRCT region. DNA binding, both
sequence- and non-sequence-specific, is commonly achieved through
interaction of an -helix with the major groove. In nonspecific interac-
tions, side chains of helical residues interact primarily with the back-
bone phosphate of theDNA andweakly, typically via bridgingwaters, to
the bases (40). Because there are any number of ways in which such
interactions can be achieved, there is little evolutionary force to main-
tain sequence conservation in a helix that is meant only for nonspecific
interaction with the DNA. Thus we propose that helix 1 lies within
the major groove of the DNA and provides the majority of the protein-
DNA contacts. This model would be consistent with reduced affinity
binding to duplex DNA containing unpaired bases, because this would
be expected to distort the major groove reducing the ability of the helix
to productively interact with both phosphate backbones simulta-
neously. It seems likely that the binding to the conserved feature on the
DNA, the 5-phosphate, occurs through a conserved motif on the pro-
tein. The conserved, positively charged patch containing Thr-415 is
clearly the likely site of this interaction. Even if these suppositions are
correct, the currently available data cannot provide any insight into the
relative orientation of helix 1 and the BRCT domain. Thus a three-
dimensional structure of the protein-DNA complex remains an impor-
tant goal. However, given the quality of the NMR data of the complex
(see Ref. 32 for details), a high resolution structure determination may
prove to be beyond reach.
Potential Conserved Mechanism—An increasing number of BRCT
domains have been reported to bind DNA. Early reports suggested that
BRCT domains could bind the termini of DNA (10). It seems likely that
this interaction is an artifact of the phosphoserine peptide binding activ-
ities more recently attributed to these proteins (6). However, recent
reports clearly identify DNA binding by the BRCT domain of bacterial
ligases (44), the most closely related sequences to RFC p140. Not only
are the residues of the charged patch conserved in these proteins, but
mutations of these residues disruptDNAbinding or related functions in
the context of the full-length ligase (39). In our secondary structure
prediction exercise we found that the trans-lesion polymerase Rev1
contains sequences N-terminal to the BRCT domain that likely form an
-helix in addition to the conserved, positively charged patch. We have
cloned and purified a Rev1 protein consisting of the N-terminal -helix
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FIGURE 6. The effect of pointmutations onDNAbindingbyRFCp140-(375–480).A, the gel retardation assaywas used to detect protein-DNA complex formation. 20, 100, or 200
fmol of the indicatedproteinwas added to 20 fmol of 32P-labeled oligo 1. The lanemarkedwith an asterisk containednoprotein. B, quantification ofDNA-protein complex formation.
The intensity of the bands inAwas determined using a phosphor imager. The percentage of the total shift (DNA-protein complex, black arrow inA) was calculated as described under
Materials and Methods.” C, to test the model of DNA binding, two further mutants in p140-(375–480), R480A and K445A, were generated. 20 fmol of 32P-labeled oligo 1 was added
to 100 fmol R480A, K445A, or wt protein and analyzed by gel retardation.
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and the BRCT domain. Preliminary experiments indicate that the Rev1
BRCT region does indeed bind DNA.Whether or not the DNA binding
is relevant in light of the known phosphoserine peptide binding is not
yet known however (8). In any case, it does seem likely that despite the
overall poor sequence conservation with the BRCT domain family, the
conserved positively charged patch surrounding Thr-415 in human
RFC, serves a dual role enabling DNA binding for some BRCT domains
and phosphoserine-dependent peptide binding for others.
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